QALBRITIX
Live / Applied — Second extension granted (statement of use) (as of 30 Oct 2025)
What this means for you
Not registered yet, but its 12 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98645343
- Mark type
- Stylized text
- Filed
- 12 Jul 2024
- Published for opposition
- 12 Nov 2024
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of respiratory, inflammatory, and immunological diseases and disorders; pharmaceutical preparations for the prevention and treatment of chronic obstructive pulmonary disease (COPD)
Owner
- Sanofi Biotechnology, Gentilly, FR
- Sanofi Biotechnology, Gentilly, FR
Prosecution history
- 30 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Oct 2025 — SOU EXTENSION 2 GRANTED
- 30 Oct 2025 — SOU EXTENSION 2 FILED
- 30 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 May 2025 — SOU EXTENSION 1 GRANTED
- 13 May 2025 — SOU EXTENSION 1 FILED
- 13 May 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Nov 2024 — PUBLISHED FOR OPPOSITION